The combination of dibenzazepine and a DOT1L inhibitor enables a stable maintenance of human naïve-state pluripotency in non-hypoxic conditions.

Isono W, Kawasaki T, Ichida JK, Ayabe T, Hiraike O, Umezawa A, Akutsu H

Open source

DOI
10.1016/j.reth.2020.08.001
Published
2020 Dec
Container
Regenerative therapy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.reth.2020.08.001,
  title = {The combination of dibenzazepine and a DOT1L inhibitor enables a stable maintenance of human naïve-state pluripotency in non-hypoxic conditions.},
  author = {Isono W and Kawasaki T and Ichida JK and Ayabe T and Hiraike O and Umezawa A and Akutsu H},
  year = {2020},
  journal = {Regenerative therapy},
  doi = {10.1016/j.reth.2020.08.001},
  url = {https://doi.org/10.1016/j.reth.2020.08.001}
}

RIS

TY  - JOUR
TI  - The combination of dibenzazepine and a DOT1L inhibitor enables a stable maintenance of human naïve-state pluripotency in non-hypoxic conditions.
AU  - Isono W
AU  - Kawasaki T
AU  - Ichida JK
AU  - Ayabe T
AU  - Hiraike O
AU  - Umezawa A
AU  - Akutsu H
PY  - 2020
JO  - Regenerative therapy
DO  - 10.1016/j.reth.2020.08.001
UR  - https://doi.org/10.1016/j.reth.2020.08.001
ER  - 

APA

W, I., T, K., JK, I., T, A., O, H., A, U., & H, A. (2020). The combination of dibenzazepine and a DOT1L inhibitor enables a stable maintenance of human naïve-state pluripotency in non-hypoxic conditions.. Regenerative therapy. https://doi.org/10.1016/j.reth.2020.08.001

Source records